Go Deep
Pulmonx Corporation
Pulmonx Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,695 | -1.5 | 1.95 | 1.43 | 169.01 |
| Oct 2026 | 18,536 | -1.6 | 2.03 | 1.43 | 175.68 |
| Oct 2026 | 18,695 | -1.5 | 1.95 | 1.43 | 168.59 |
| Oct 2026 | 18,764 | -1.5 | 1.92 | 1.43 | 165.93 |
| Oct 2026 | 18,604 | -1.6 | 1.99 | 1.43 | 172.57 |
| Oct 2026 | 18,581 | -1.6 | 2.00 | 1.43 | 173.09 |
| Oct 2026 | 18,467 | -1.6 | 2.06 | 1.43 | 177.45 |
Pulmonx Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 22,756,000.0 | 20,586,000.0 | 22,598,000.0 | 21,502,000.0 |
| Net Profit | -10,080,000.0 | -13,654,000.0 | -10,425,000.0 | -13,957,000.0 |
| EPS | -0.2 | -0.3 | -0.2 | -0.3 |
Pulmonx Corporation Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 90,497,000.0 | 83,789,000.0 | 68,675,000.0 | 53,662,000.0 |
| Net Profit | -54,003,000.0 | -56,394,000.0 | -60,843,000.0 | -58,923,000.0 |
| EPS | -1.3 | -1.4 | -1.6 | -1.6 |
Pulmonx Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 129,291,000.0 | 162,850,000.0 | 177,781,000.0 | 193,676,000.0 | — |
| Total Liabilities | 75,175,000.0 | 77,041,000.0 | 59,466,000.0 | 39,669,000.0 | — |
| Total Equity | 54,116,000.0 | 85,809,000.0 | 118,315,000.0 | 154,007,000.0 | — |
Owes vs Owns
Pulmonx Corporation owed $0.66 for every $1 it owned in Jun 2026, up from $0.20 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.66× | 0.58× | 0.47× | 0.33× | 0.20× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Pulmonx Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 53.9%Receivables 9.8%Inventory 12.3%Fixed assets (tangible) 15.7%Intangible assets 1.8%Other assets 6.5%
How it's funded — Dec 2025
Long-term debt 28.6%Payables 3.0%Other liabilities 26.4%Shareholders' equity 41.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 69.8 | 101.5 | 117.1 | 141.1 |
| Receivables | 12.7 | 13.8 | 13.0 | 9.3 |
| Inventory | 15.8 | 16.9 | 16.7 | 14.6 |
| Fixed assets (tangible) | 20.2 | 21.5 | 7.4 | 10.5 |
| Intangible assets | 2.3 | 2.3 | 2.4 | 2.5 |
| Long-term investments | 0.0 | 0.0 | 14.4 | 5.9 |
| Other assets | 8.5 | 6.9 | 6.7 | 9.8 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 3.2 | 2.2 | 0.1 |
| Long-term debt | 37.0 | 34.0 | 35.1 | 17.2 |
| Payables | 3.9 | 3.8 | 1.5 | 1.8 |
| Other liabilities | 34.2 | 36.0 | 20.7 | 20.6 |
| Shareholders' equity | 54.1 | 85.8 | 118.3 | 154.0 |
| Net tangible assets | 51.8 | 83.5 | 116.0 | 151.5 |
Pulmonx Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -32,376,000.0 | -31,537,000.0 | -37,610,000.0 | -45,083,000.0 | — |
| Investing Activities | 30,482,000.0 | 17,476,000.0 | -2,007,000.0 | -4,225,000.0 | — |
| Financing Activities | 833,000.0 | 1,363,000.0 | 21,400,000.0 | 2,419,000.0 | — |